Coronavirus: China’s Sinovac investing US$60 million in Chile vaccine facility
- The plant will be built in the Santiago region in early 2022. Sinovac will also build a research and development centre in the northern region of Antofagasta
- The Chilean government bet big on the Chinese company’s CoronaVac shot, with 19.6 million doses already delivered
Chinese pharmaceutical Sinovac Biotech on Wednesday said it will build a fill-and-finish vaccine plant in Chile with an investment of US$60 million, consolidating its presence in the Latin American nation that has used its Covid-19 shot the most.
Chile has run one of the world’s fastest vaccination campaigns, so far fully vaccinating more than 60 per cent of its population, including with 19.6 million doses of Sinovac’s CoronaVac already delivered.
The plant will be built in the Santiago region in the first quarter of 2022.
Sinovac will also build a research and development centre in the northern region of Antofagasta.
01:30
WHO approves Sinovac Biotech’s coronavirus vaccine for emergency use
Since mid-July, Sinovac executives have been looking at the possibility of building a plant in Chile with a capacity to produce 50 million vaccines of diverse types.